COVID Antiviral Paxlovid Provides “No Significant Benefit” to Vaccinated Seniors
by Amber Baker
Paxlovid, the antiviral drug that became the go-to treatment for SARS-CoV-2 infections during the pandemic, did not reduce hospitalizations or death in ...
AstraZeneca’s COVID-19 Vaccine Not Recommended for People Over 65 in Germany
by Carolyn Hendler, JD
Health officials in Germany have cautioned that the AstraZeneca/Oxford University COVID-19 vaccine (AZD1222) should not be given to people over the ...
ACIP Updates Influenza Vaccine Guidelines for Seniors
by Rishma Parpia
The Advisory Committee on Immunization Practices (ACIP) for the U.S. Centers for Disease Control and Prevention (CDC) has issued new ...
Flu Vaccines Failing Seniors
by Joseph Mercola, DO | Guest Writer
Opinion | Ever since the U.S. Centers for Disease Control and Prevention (CDC) began recommending that all Americans six months ...
Flu Shot Fails to Protect Seniors and May Increase Miscarriages
by Joseph Mercola, DO | Guest Writer
Opinion | Flu season is creeping up on us again and there are widespread calls to get your annual flu shot, ...
Strong Evidence Linking Aluminum and Alzheimer’s
by Chris Exley, PhD | Guest Writer
There has been a strong link between human exposure to aluminium and the incidence of Alzheimer’s disease for half a ...
Flu Shots Rarely Work for People Over Age 65
by Kate Raines
For the 2014-2015 “flu season,” the reported effectiveness of the annual flu shot was only 14% in those over age ...
In this section
Latest
Popular
Comments
Latest
CDC’s ACIP Forms Workgroup to Back New Lyme Disease Vaccine and Monoclonal Antibody Products
by Carolyn Hendler, JD
Popular
Comments
San on Flu Shot Recipients “More Likely” to Get Influenza Than Unvaccinated
Mary on Flu Shot Recipients “More Likely” to Get Influenza Than Unvaccinated
Bebe on Flu Shot Recipients “More Likely” to Get Influenza Than Unvaccinated
David N. on The Truth About Whooping Cough in the U.S.
B.C. on Flu Shot Recipients “More Likely” to Get Influenza Than Unvaccinated
